Recent progress in molecular simulation methods for drug binding kinetics

Due to the contribution of drug-target binding kinetics to drug efficacy, there is a high level of interest in developing methods to predict drug-target binding kinetic parameters. During the review period, a wide range of enhanced sampling molecular dynamics simulation-based methods has been develo...

Full description

Saved in:
Bibliographic Details
Main Authors: Nunes-Alves, Ariane (Author) , Kokh, Daria B. (Author) , Wade, Rebecca C. (Author)
Format: Article (Journal)
Language:English
Published: 6 August 2020
In: Current opinion in structural biology
Year: 2020, Volume: 64, Pages: 126-133
DOI:10.1016/j.sbi.2020.06.022
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.sbi.2020.06.022
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0959440X20301214
Get full text
Author Notes:Ariane Nunes-Alves, Daria B Kokh and Rebecca C Wade
Description
Summary:Due to the contribution of drug-target binding kinetics to drug efficacy, there is a high level of interest in developing methods to predict drug-target binding kinetic parameters. During the review period, a wide range of enhanced sampling molecular dynamics simulation-based methods has been developed for computing drug-target binding kinetics and studying binding and unbinding mechanisms. Here, we assess the performance of these methods considering two benchmark systems in detail: mutant T4 lysozyme-ligand complexes and a large set of N-HSP90-inhibitor complexes. The results indicate that some of the simulation methods can already be usefully applied in drug discovery or lead optimization programs but that further studies on more high-quality experimental benchmark datasets are necessary to improve and validate computational methods.
Item Description:Gesehen am 25.11.2020
Physical Description:Online Resource
DOI:10.1016/j.sbi.2020.06.022